  *** Nfkb1[Ab] oligo-binding[EMSA] is increased irt Cd40L (5 hr)
    *** cells: mSpBCs in BMS
    *** source: 12374738-Fig-5d
  *** Nfkb1[Ab] oligo-binding[EMSA] is increased irt anti-Cd40 (2 hr)
    *** cells: RAMOS in BMS
    *** oligo: "Lta-Nfkb" 5-CCTGGGGGCTTCCCCGGG-3
    *** source: 9541585-Fig-2a
  *** Nfkb1[Ab] oligo-binding[EMSA] is increased irt anti-Cd40 (30 min)
    *** cells: BL2 in BMS "nuclear-extracts"
    *** unaffected by: IL4 [cotreatment]
    *** source: 14978013-Fig-5
  *** Nfkb1[Ab] oligo-binding[EMSA] is increased irt anti-Cd40 (times)
    *** cells: HEK293<xCd40> in BMS
    *** times: 0 30+ 360+ min
    *** source: 12374738-Fig-4c
  *** Nfkb1[Ab] oligo-binding[EMSA] is increased irt Cd40L (12 hr)
    *** cells: CL01 in BMS "nuclear-extracts"
    *** oligo: "Nfkb" 5-GTGTCTGGACTCCCCCTCGCC-3
    *** enhanced by: IL4 [cotreatment]
    *** source: 10228008-Fig-7a
  *** Nfkb1[Ab] oligo-binding[EMSA] is increased irt Cd40L (12 hr)
    *** cells: hTonsillarBCs in BMS "nuclear-extracts"
    *** oligo: "Nfkb" 5-GTGTCTGGACTCCCCCTCGCC-3
    *** enhanced by: IL4 [cotreatment]
    *** source: 10228008-Fig-7a
  *** Nfkb1[Ab] oligo-binding[EMSA] is increased irt Cd40L (30 min)
    *** cells: hPBMonos in BMS
    *** source: 10395671-Fig-2
  *** Nfkb1[Ab] oligo-binding[EMSA] is increased irt Cd40L (30 min)
    *** cells: hTonsillarBCs in BMS
    *** source: 10395671-Fig-2

